Long-term outcomes of treatment of hyperthyroidism in Ireland

  • A. C. Leary
  • G. Grealy
  • T. M. Higgins
  • N. Buckley
  • D. G. Barry
  • D. Murphy
  • J. B. Ferriss


We investigated the long-term outcome of treatment in 159 patients with hyperthyroidism first seen between 1979 and 1992. Median duration of follow-up was 10 1/2 years. We also enquired into current practice for the follow-up of hyperthyroidism by other endocrinologists in Ireland.

Seven cases of unrecognised hyperthyroidism (4 per cent) and one of unrecognised hypothyroidism were identified. Among patients with Graves’ disease, of those treated with an antithyroid drug, 28 per cent were in remission, 68 per cent had relapsed and 4 per cent had become hypothyroid. Of those treated by sub-total thyroidectomy, 31 per cent were in remission, 19 per cent had relapsed, 19 per cent were hypothyroid and 31 per cent were sub-clinically hypothyroid. Among patients treated with radioiodine, 19 per cent were euthyroid, 3 per cent were still hyperthyroid and three-quarters had become hypothyroid. In contrast, after radioiodine for toxic nodular goitre, 63 per cent were euthyroid and only 32 per cent had become hypothyroid (Chi Squared v. Graves’ disease, P=0.001).

Of 73 patients receiving thyroxine replacement, plasma TSH was normal in only 41 per cent, although 82 per cent of patients had been seen by the family doctor within the previous 12 months. Seven of 17 other endocrinologists undertook long-term follow-up of hyperthyroid patients in their specialist clinics but none was using a computerised system to co-ordinate this. The findings confirm that careful follow-up is required for all hyperthyroid patients. The family doctor is well positioned to undertake this, but education and auditing are required.


Hyperthyroidism Thyroid Stimulate Hormone Family Doctor Antithyroid Drug Carbimazole 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Sridama, V., McCormick, M., Kaplan, E. L., Fauchet, R, De Groot. L. J. Long-term follow-up study of compensated low-dose131I therapy for Graves’ disease. N. Engl. J. Med. 1984; 311: 426–432.PubMedGoogle Scholar
  2. 2.
    Hedley, A. J., Young, R. E., Jones, S. J., Alexander, W. D., Brewsher, P. D. and Scottish Automated Follow-up Register Group. Antithyroid drugs in the treatment of hyperthyroidism of Graves’ disease: Long-term follow-up of 434 patients. Clin. Endocrinol. 1989: 31: 209–218.CrossRefGoogle Scholar
  3. 3.
    Franklyn, J. A. The management of hyperthyroidism. N. Engl. J. Med. 1994; 330: 1731–1738.PubMedCrossRefGoogle Scholar
  4. 4.
    Barber, S. G., Carter, D. J., Bishop, J. M. System for long-term review of patients at risk of becoming hypothyroid: Further experience. Lancet 1977; 2: 967–970.PubMedCrossRefGoogle Scholar
  5. 5.
    Scottish Automated Follow-up Register Group. Thyroxine replacement therapy: Prescribing patterns and problems in 2710 patients. Br. Med. J. 1980; 218: 969–971.Google Scholar
  6. 6.
    Jung, R. T., Scott, A., Chong, P., Browning, M., Waugh, N. A new Pick based computer thyroid register based on the National Safur requirements for local usage. Health Bull (Edinb.) 1991; 49: 244–248.Google Scholar
  7. 7.
    Dunne, F. P. M., Feely, M. P., Ferriss, J. B., Keohane, C. Murphy, D., Perry, I. Hyperthyroidism, inappropriate plasma TSH and pituitary adenoma in three patients, two receiving long-term phenothiazine therapy. Q. J. Med. 1990; 75: 345–354.PubMedGoogle Scholar
  8. 8.
    Franklyn, J. A., Daykin, J., Drolc, Z., Farmer, M., Sheppard, M. C. Long-term follow-up of treatment of thyrotoxicosis by three different methods. Clin. Endocrinol. 1991; 34: 71–76.CrossRefGoogle Scholar
  9. 9.
    Hermus, A. R., Huysmans, D. A. Treatment of benign nodular thyroid disease. N. Engl. J. Med. 1998; 338: 1438–1447.PubMedCrossRefGoogle Scholar
  10. 10.
    Smith, A., McKenna, T. J. Management of patients with diffuse toxic goitre in Ireland, a country with low iodine intake. Ir. J. Med. Sci. 1992; 161: 597–599.PubMedCrossRefGoogle Scholar
  11. 11.
    Sugrue, D., McEvoy, M., Feely, J., Drury, M. I. Hyperthyroidism in the land of Graves’: Results of treatment by surgery, radioiodine and carbimazole in 837 cases. Q. J. Med. 1980; 193: 51–61.Google Scholar
  12. 12.
    Collier, J. F., Maguire, S., McGing, P., Codd, M. B., Kyne, F., Wright, E., Halton, K., UaConaill, D., Sugrue, D. D. Cholesterol levels in normal Irish adults: The Mater Hospital Cholesterol Screening Survey. Ir. J. Med. Sci. 1996; 165: 177–181.PubMedCrossRefGoogle Scholar
  13. 13.
    Lindsay, R. S., Toft, A. D. Hypothyroidism. Lancet 1997; 349: 413–417.PubMedCrossRefGoogle Scholar
  14. 14.
    Bearcroft, C. P., Toms, G. C., Williams, S. J., Noonan, K., Monson, J. P. Thyroxine replacement in post-radioiodine hypothyroidism. Clin. Endocrinol. 1991; 34: 115–118.CrossRefGoogle Scholar
  15. 15.
    Parle, J. V., Franklyn, J. A., Sheppard, M. C. Thyroxine replacement therapy. Lancet 1991; 337: 171.CrossRefGoogle Scholar
  16. 16.
    Baxter, M. A., Stewart, P. M., Daykin, J., Sheppard, M. C., Franklyn, J. A. Radioiodine therapy for hyperthyroidism in young patients — perception of risk and use. Q. J. Med. 1993; 86: 495–499.PubMedGoogle Scholar
  17. 17.
    George, S., Franklyn, J. Radioiodine therapy for hyperthyroidism — Perception of risk. Q. J. Med. 1996; 89: 483–484.Google Scholar
  18. 18.
    Guidelines for the use of radioiodine in the management of hyperthyroidism: A summary. J. R. Coll. Physicians Lond. 1995; 29: 464–469.Google Scholar
  19. 19.
    Preece, J. Supervision of Chronic Disease. In the Use of Computers in General Practice (2nd Edition): Edinburgh, Churchill Livingstone, 1990; 87–98.Google Scholar
  20. 20.
    Orton, K. Screening and Surveillance of Disorders of Metabolism in Adults. In Screening and Surveillance in General Practice. Eds. Hart, C. R., Burke, P., Edinburgh, Churchill Livingstone, 1992, 213–227.Google Scholar

Copyright information

© Springer-Verlag 1999

Authors and Affiliations

  • A. C. Leary
    • 1
  • G. Grealy
    • 1
  • T. M. Higgins
    • 1
  • N. Buckley
    • 3
  • D. G. Barry
    • 4
  • D. Murphy
    • 2
  • J. B. Ferriss
    • 1
  1. 1.Departments of MedicineCork University Hospital and University CollegeCork
  2. 2.Department of BiochemistryCork University Hospital and University CollegeCork
  3. 3.Department of StatisticsCork University Hospital and University CollegeCork
  4. 4.Department of StatisticsUniversity of LimerickIreland

Personalised recommendations